Owaisi Hospital & Research Centre Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT01187966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Owasis Hospital & Research Centre, Hyderabad

Active Ingredients

Drugs in Phase 3 Trials (1)

safinamide (xadago) (1 trial)

Drugs in Other Trials (3)

adapalene (differin) (1 trial)

clindamycin (cleocin) (1 trial)

tretinoin (Retin-A) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4